Ataxia Market
According to Intent Market Research, the Ataxia Market is expected to grow from USD 3.1 Billion in 2024-e at a CAGR of 12.4% to touch USD 6.3 Billion by 2030. The Ataxia Market is dominated by key players such as Novartis AG, Pfizer Inc., Merck & Co., Inc., Bayer AG, Amgen Inc., and Genzyme Corporation.